Monday
Jul092012
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.
Foglietta M, Neelapu SS, Kwak LW, Jiang Y, Nattamai D, Lee ST, Fowler DH, Sportes C, Gress RE, Steinberg SM, Vence LM, Radvanyi L, Dwyer KC, Qazilbash MH, Bryant RN, Bishop MR
Bone Marrow Transplant. 2012 Jul 9. doi: 10.1038/bmt.2012.132. [Epub ahead of print]
Date:
July 9, 2012
July 9, 2012 Categories
Clinical,
KLH in Therapeutic Vaccine
Clinical,
KLH in Therapeutic Vaccine 